{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:39:22Z","timestamp":1760099962219},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T00:00:00Z","timestamp":1182297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2007,9,18]]},"DOI":"10.1007\/s00520-007-0277-0","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T05:49:05Z","timestamp":1182232145000},"page":"1213-1217","source":"Crossref","is-referenced-by-count":9,"title":["Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter"],"prefix":"10.1007","volume":"15","author":[{"given":"Giuseppe","family":"Curigliano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Ghisini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Peruzzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalba","family":"Torrisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Dellapasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,20]]},"reference":[{"key":"277_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","volume":"78","author":"N Levitan","year":"1999","unstructured":"Levitan N, Dowlati A, Remick SC et al (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using Medicare claims data. Medicine (Baltimore) 78:285\u2013291","journal-title":"Medicine (Baltimore)"},{"key":"277_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000046583","volume":"106","author":"FR Rickles","year":"2001","unstructured":"Rickles FR, Levine MN (2001) Epidemiology of thrombosis in cancer. Acta Haematol 106:6\u201312","journal-title":"Acta Haematol"},{"key":"277_CR3","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2003.08.008","volume":"21","author":"M Verso","year":"2003","unstructured":"Verso M, Agnelli G (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21:3665\u20133675","journal-title":"J Clin Oncol"},{"key":"277_CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","volume":"112","author":"MM Bern","year":"1990","unstructured":"Bern MM, Lokich JJ, Wallach SR et al (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112:423\u2013428","journal-title":"Ann Intern Med"},{"key":"277_CR5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2141.1998.00732.x","volume":"101","author":"P Boraks","year":"1998","unstructured":"Boraks P, Seale J, Price J et al (1998) Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with hematological malignancies. Br J Haematol 101:483\u2013486","journal-title":"Br J Haematol"},{"key":"277_CR6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1445-5994.2002.00171.x","volume":"32","author":"DC Heaton","year":"2002","unstructured":"Heaton DC, Han DY, Inder A (2002) Minidose (1\u00a0mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 32:84\u201388","journal-title":"Intern Med J"},{"key":"277_CR7","doi-asserted-by":"crossref","first-page":"703a","DOI":"10.1182\/blood-2002-01-0048","volume":"100","author":"S Couban","year":"2002","unstructured":"Couban S, Goodyear M, Burnell M et al (2002) A randomised double blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer. Blood 100:703a (Abstract)","journal-title":"Blood"},{"issue":"4","key":"277_CR8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.2003.02.042","volume":"21","author":"G Masci","year":"2003","unstructured":"Masci G, Magagnali M, Zucali PA et al (2003) Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? J Clin Oncol 21(4):736\u2013739","journal-title":"J Clin Oncol"},{"issue":"4","key":"277_CR9","first-page":"3143","volume":"25","author":"M Magagnoli","year":"2005","unstructured":"Magagnoli M, Masci G, Castagna L et al (2005) Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients. Anticancer Res 25(4):3143\u20133147","journal-title":"Anticancer Res"},{"key":"277_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","volume":"75","author":"M Monreal","year":"1996","unstructured":"Monreal M, Alastrue A, Rull M et al (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices: Prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75:251\u2013253","journal-title":"Thromb Haemost"},{"key":"277_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","volume":"109","author":"P Massicotte","year":"2003","unstructured":"Massicotte P, Julian JA, Gent M et al (2003) An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line related thrombotic complications in children: the PROTEKT trial. Thromb Res 109:101\u2013108","journal-title":"Thromb Res"},{"key":"277_CR12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bmt.1702675","volume":"26","author":"SW Lagro","year":"2000","unstructured":"Lagro SW, Verdonck LF, Borel Rinkes IH et al (2000) No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients. Bone Marrow Transplant 26:1103\u20131106","journal-title":"Bone Marrow Transplant"},{"key":"277_CR13","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","volume":"23","author":"M Verso","year":"2005","unstructured":"Verso M, Agnelli G, Bertoglio S et al (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 23:4057\u20134062","journal-title":"J Clin Oncol"},{"key":"277_CR14","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","volume":"8","author":"ZM Ruggeri","year":"2002","unstructured":"Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227\u20131234","journal-title":"Nat Med"},{"issue":"3","key":"277_CR15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2006-939431","volume":"32","author":"JJ Michiels","year":"2006","unstructured":"Michiels JJ, Berneman Z, Van Bockstaele D et al (2006) Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Semin Thromb Hemost 32(3):174\u2013207 (review)","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"277_CR16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1538-7836.2006.01928.x","volume":"4","author":"MM Hovens","year":"2006","unstructured":"Hovens MM, Snoep JD, Tamsma JT et al (2006) Aspirin in the prevention and treatment of venous thromboembolism. J Thromb Haemost 4(7):1470\u20131475","journal-title":"J Thromb Haemost"},{"issue":"16","key":"277_CR17","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","volume":"354","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Fox KA, Hacke W et al (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354(16):1706\u20131717","journal-title":"N Engl J Med"},{"key":"277_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1008364801718","volume":"11","author":"L Orlando","year":"2000","unstructured":"Orlando L, Colleoni M, Nol\u00e8 F et al (2000) Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required? Ann Oncol 11:117\u2013118","journal-title":"Ann Oncol"},{"key":"277_CR19","first-page":"677","volume":"65","author":"RB Weiss","year":"1981","unstructured":"Weiss RB, Tormey DC, Holland JF et al (1981) Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep 65:677\u2013679","journal-title":"Cancer Treat Rep"},{"key":"277_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V62.1.14.14","volume":"62","author":"FR Rickles","year":"1983","unstructured":"Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau\u2019s syndrome revised. Blood 62:14\u201331","journal-title":"Blood"},{"issue":"Suppl 4","key":"277_CR21","doi-asserted-by":"crossref","first-page":"391S","DOI":"10.1378\/chest.102.4_Supplement.391S","volume":"102","author":"GP Clagett","year":"1992","unstructured":"Clagett GP, Anderson FA, Levine MN et al (1992) Prevention of venous thromboembolism. Chest 102(Suppl 4):391S\u2013407S","journal-title":"Chest"},{"key":"277_CR22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0002-8703(96)90321-X","volume":"132","author":"A Piccioli","year":"1996","unstructured":"Piccioli A, Prandoni P, Ewenstein BM et al (1996) Cancer and venous thromboembolism. Am Heart J 132:850\u2013855","journal-title":"Am Heart J"},{"key":"277_CR23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1985.3.5.710","volume":"3","author":"JJ Lokich","year":"1985","unstructured":"Lokich JJ, Bothe A, Benotti P et al (1985) Complications and management of implanted venous access catheters. J Clin Oncol 3:710\u2013717","journal-title":"J Clin Oncol"},{"key":"277_CR24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","volume":"343","author":"M Levine","year":"1994","unstructured":"Levine M, Hirsch J, Gent M et al (1994) Double blind randomized trial of very low dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 343:886\u2013889","journal-title":"Lancet"},{"key":"277_CR25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/106002809402800408","volume":"28","author":"MA Scarfe","year":"1994","unstructured":"Scarfe MA, Israel MK (1994) Possible drug interaction between warfarin and combination of levamisole and fluorouracil. Ann Pharmacother 28:464\u2013467","journal-title":"Ann Pharmacother"},{"issue":"4","key":"277_CR26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/annonc\/mdh146","volume":"15","author":"M Mandala","year":"2004","unstructured":"Mandala M, Curigliano G, Bucciarelli P et al (2004) Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and central venous catheter. Ann Oncol 15(4):590\u2013593","journal-title":"Ann Oncol"},{"issue":"2","key":"277_CR27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","volume":"350","author":"R Landolfi","year":"2004","unstructured":"Landolfi R, Marchioli R, Kutti J et al (2004) Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 350(2):114\u2013124","journal-title":"N Engl J Med"},{"issue":"9098","key":"277_CR28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","volume":"351","author":"The Medical Research Council\u2019s General Practice Research Framework","year":"1998","unstructured":"The Medical Research Council\u2019s General Practice Research Framework (1998) Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 351(9098):233\u2013241","journal-title":"Lancet"},{"issue":"12","key":"277_CR29","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4065\/80.12.1568","volume":"80","author":"R Baz","year":"2005","unstructured":"Baz R, Li L, Kottle-Marchant K, Srkalovic G et al (2005) The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma. Mayo Clin Proc 80(12):1568\u20131574","journal-title":"Mayo Clin Proc"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-007-0277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-007-0277-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-007-0277-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T04:51:14Z","timestamp":1587617474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-007-0277-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,20]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,18]]}},"alternative-id":["277"],"URL":"https:\/\/doi.org\/10.1007\/s00520-007-0277-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,20]]}}}